Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
life sciences
national blog main
national top stories
new york blog main
new york top stories
spinal muscular atrophy
3
×
bill cassidy
biotech
gene therapy
hemophilia
johnson & johnson
mark warner
medicaid
meiragtx
novartis
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
startups
zolgensma
abiraterone
ac immune
achromatopsia
acorda therapeutics
adeno-associated virus
aduro biotech
agenus
aldeyra therapeutics
aleksandra rizo
alexandria venture investments
alexion pharmaceuticals
altitude life science ventures
alzheimer's disease
american society of gene and cell therapy
apalutamide
arch venture partners
What
gene
3
×
therapy
age
alzheimer’s
bigger
biggest
bio
come
companies
crude
cutting
deal
despite
different
drug
edge
effects
emerging
encoded
fail
gave
help
illumina’s
increases
j
johnson
lasting
latest
limited
limits
long
medicine
meiragtx
morning
nabs
past
pharmaceutical
plan
prescription
price
Language
Current search:
gene
×
" spinal muscular atrophy "
×
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy